Horizon Two: HR NDMM (MMRC-100)

Abroad (travel likely)RecruitingPHASE2

Conditions

High Risk Newly Diagnosed Multiple Myeloma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Emory University, Atlanta, Georgia, United States
Contact: Study coordinator (Bryan Burton) · bryan.james.burton@emory.edu · 404-727-7631
UChicago Medicine, Chicago, Illinois, United States
Contact: Study coordinator (Joanna Pagacz) · joanna.pagacz@bsd.uchicago.edu · 1-888-824-0200
Karmanos Cancer Institute, Detroit, Michigan, United States
Contact: Study coordinator (Christy Houde) · houdec@karmanos.org · 800-527-6266
Mayo Clinic, Rochester, Minnesota, United States
Contact: Study coordinator (Jessica Haug) · Haug.Jessica@mayo.edu · 507-266-7890
Washington University Medical Center, St Louis, Missouri, United States
Contact: Study coordinator (Alexander Craig) · craiga@wustl.edu
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Laura Guttentag) · guttenl@mskcc.org
UNC, Chapel Hill, North Carolina, United States
Contact: Study coordinator (Courtney Kelly) · courtney_kelly@med.unc.edu · 919-962-8335

Study leads

Hearn Jay Cho, MD, PhD
Principal Investigator
Multiple Myeloma Research Foundation

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

Multiple Myeloma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · Orange, United States

Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma

Multiple Myeloma · Primary Plasma Cell Leukemia · Extramedullary Multiple Myeloma

Abroad (travel likely)RecruitingPHASE2

Wuhan, China

A Dietary Study for People With Multiple Myeloma

Multiple Myeloma

Abroad (travel likely)Recruiting

Basking Ridge, United States · Middletown, United States

Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Patients

Newly Diagnosed Multiple Myeloma

Abroad (travel likely)RecruitingPHASE2, PHASE3

Berlin, Germany · Bielefeld, Germany